市场调查报告书
商品编码
1463701
欧洲眼底相机市场预测至 2030 年 - 区域分析 - 按类型、便携性、应用和最终用户Europe Fundus Cameras Market Forecast to 2030 - Regional Analysis - by Type, Portability, Application, and End User |
2022年欧洲眼底相机市场价值为1.8487亿美元,预计到2030年将达到3.3755亿美元;预计2022年至2030年CAGR为7.8%。
创新产品的推出推动欧洲眼底相机市场
医疗器材公司专注于新产品的开发和推出,并获得相应监管机构的批准。以下提到了促进全球眼底市场的一些最新发展。
2021年10月,NIDEK株式会社宣布推出“Retina Scan Duo 2”,这是一种组合光学相干断层扫描(OCT)和眼底摄影系统。新推出的产品具有使用者友善的功能,有助于提高眼部筛检和临床效率。 Retina Scan Duo 2 采用新颖的影像增强技术,可从单张影像产生高画质影像,确保病患舒适度。 2023 年 1 月,领先的医疗设备和软体解决方案提供商 Topcon Healthcare 宣布推出“NW500”,这是一款用户友好的机器人眼底相机,可确保提供可靠且清晰的影像。新产品还可以简化诊断实验室的工作流程,增强患者体验,并让筛检人员在光线充足的环境中取得视网膜影像。而且,他们不需要要求患者散瞳。此外,该产品还可以在三个传统固视点(视盘、中心和黄斑)和用于週边摄影的九个固视位置提供优质的彩色眼底影像。 2021年6月,Coburn Technologies宣布推出HFC-1免散瞳眼底相机,这是一款由Huvitz, Co., Ltd.製造的新型视网膜相机。快速、以及可靠的视网膜成像和测量。
欧洲眼底相机市场概况
根据《英国眼科杂誌》披露的统计数据,到 2050 年,导致不可逆失明和视力严重受损的主要原因——年龄相关性黄斑部病变将影响 7,700 万欧洲人。根据美国眼科学会2023年报告,由于第2型糖尿病发生率上升,3%-4.1%的欧洲人受到糖尿病视网膜病变的影响。例如,英国,43.3%;瑞士,42.3%;波兰,31.8%;德国占实际发生率29.9%。此外,世界卫生组织 (WHO) 报告称,苏格兰患糖尿病的人数有所增加。此外,英国是欧洲地区对所有12岁以上糖尿病患者进行全国筛检最多的国家,共有900万名患者,占人口的6%。此外,欧洲地区不断增加的产品批准进一步提高了美国眼底相机市场的采用率。根据记录,2022 年 8 月,Formycon AG(“Formycon”)、Polpharma Biologics Group BV(“Polpharma Biologics”)和 Bioeq AG(“Bioeq”)宣布欧盟委员会(EU)授予“Ranivisio”的营销授权( Ranivisio - Ranibizumab),Lucentis 的生物相似药,旨在治疗欧盟(EU) 的几种严重视网膜疾病。上述因素将提高欧洲地区眼底相机的采用率,进而主导 2022-2030 年的市场成长。
欧洲眼底相机市场收入及 2030 年预测(百万美元)
欧洲眼底相机市场区隔
欧洲眼底相机市场根据类型、便携性、应用、最终用户和国家进行细分。
根据类型,欧洲眼底相机市场分为散瞳眼底相机、免散瞳眼底相机、混合眼底相机和ROP眼底相机。免散瞳眼底相机细分市场在 2022 年占据最大市场。
基于便携性,欧洲眼底相机市场分为手持式和桌上型。 2022 年,桌面细分市场占据了更大的市场。
根据应用,欧洲眼底相机市场分为糖尿病性视网膜病变、老年黄斑部病变、视网膜血管疾病等。 2022 年,糖尿病视网膜病变细分市场占最大市场。
根据最终用户,欧洲眼底相机市场分为医院、眼科中心等。 2022 年,医院细分市场占据最大市场份额。
根据国家/地区,欧洲眼底相机市场分为英国、德国、法国、义大利、西班牙和欧洲其他地区。 2022 年,德国在欧洲眼底相机市场份额中占据主导地位。
Nikon Corp、Topcon Corp、NIDEK CO LTD、Canon Inc、Carl Zeiss AG、Visionix USA Inc、Kowa Co Ltd、CenterVue SpA、Volk Optical Inc 和 Digital Eye Center 是欧洲眼底相机市场的一些领先参与者。
表中的内容
The Europe fundus cameras market was valued at US$ 184.87 million in 2022 and is expected to reach US$ 337.55 million by 2030; it is estimated to grow at a CAGR of 7.8% from 2022 to 2030.
Launches of Innovative Products Fuel the Europe Fundus Cameras Market
Medical device companies focus on the development and launch of new products, along with obtaining approvals from corresponding regulatory bodies. A few of the recent developments fostering the global fundus market are mentioned below.
In October 2021, NIDEK CO., LTD. announced the launch of "Retina Scan Duo 2," a combined optical coherence tomography (OCT) and fundus camera system. The newly launched product aids in enhanced eye screening and clinical efficiency with user-friendly features. Retina Scan Duo 2 incorporates a novel image enhancement technique that generates an HD image from a single-frame image, ensuring great patient comfort. In January 2023, Topcon Healthcare, a leading provider of medical devices and software solutions, announced the launch of "NW500," a user-friendly, robotic fundus camera ensuring to deliver reliable and sharp-quality images. The new product also enables a streamlined workflow in diagnostic laboratories, enhancing the patient experience and allowing the screening personnel to acquire retinal images in well-lit settings. Moreover, they don't need to ask patients to dilate their eyes. Further, the product provides excellent-quality color fundus images across the three traditional fixation points (disc, center, and macula) and the nine fixation positions for peripheral photography. In June 2021, Coburn Technologies announced the launch of the HFC-1 Non-Mydriatic Fundus Camera, a new retinal camera manufactured by Huvitz, Co., Ltd. With a highly accurate autodetection technology, the products are intended to produce sharp, quick, and reliable retinal imaging and measurements.
Europe Fundus Cameras Market Overview
The leading cause of irreversible blindness and severely impaired eyesight-age-related macular degeneration will affect 77 million Europeans by 2050, as per the statistics revealed by the British Journal of Opthalmology. According to the American Academy of Ophthalmology 2023 report, 3%-4.1% of Europeans are affected by diabetic retinopathy owing to rising type 2 diabetes. For instance, the UK, 43.3%; Switzerland, 42.3%; Poland, 31.8%; and Germany accounting, 29.9%, accounting for actual incidence. Additionally, the World Health Organization (WHO) reports Scotland has faced an increase in the number of people suffering from diabetes. Moreover, the UK is the largest country in the Europe region with nationwide screening for all patients suffering from DM above the age of 12 years, comprising 9 million patients in total, accounting for 6% of the population. Further, rising product approvals in the European region further enhance the adoption of the US fundus camera market. For records, in August 2022, Formycon AG ("Formycon"), Polpharma Biologics Group BV ("Polpharma Biologics"), and Bioeq AG ("Bioeq") announced that the European Commission (EU) granted marketing authorization for "Ranivisio" (Ranivisio - Ranibizumab), biosimilar to Lucentis intended to treat several serious retinal diseases in the European Union (EU). Such aforementioned factors will enhance the adoption of fundus camera in the European region thereby dominating the market growth during 2022-2030.
Europe Fundus Cameras Market Revenue and Forecast to 2030 (US$ Million)
Europe Fundus Cameras Market Segmentation
The Europe fundus cameras market is segmented based on type, portability, application, end user, and country.
Based on type, the Europe fundus cameras market is segmented into mydriatic fundus camera, non-mydriatic fundus camera, hybrid fundus camera, and ROP fundus camera. The non-mydriatic fundus camera segment held the largest market share in 2022.
Based on portability, the Europe fundus cameras market is bifurcated into handheld and tabletop. The tabletop segment held a larger market share in 2022.
Based on application, the Europe fundus cameras market is segmented into diabetic retinopathy, age-related macular degeneration, retinal vascular disorders, and others. The diabetic retinopathy segment held the largest market share in 2022.
Based on end user, the Europe fundus cameras market is segmented into hospitals, ophthalmology centers, and others. The hospitals segment held the largest market share in 2022.
Based on country, the Europe fundus cameras market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe fundus cameras market share in 2022.
Nikon Corp, Topcon Corp, NIDEK CO LTD, Canon Inc, Carl Zeiss AG, Visionix USA Inc, Kowa Co Ltd, CenterVue SpA, Volk Optical Inc, and Digital Eye Center are some of the leading players operating in the Europe fundus cameras market.
Table of Content